John S Papola, MD | |
250 Sylvia Ln, Allentown, PA 18104-9079 | |
(610) 481-0895 | |
Not Available |
Full Name | John S Papola |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 250 Sylvia Ln, Allentown, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346596368 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | MD030130E (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
John S Papola, MD 250 Sylvia Ln, Allentown, PA 18104-9079 Ph: (610) 481-0895 | John S Papola, MD 250 Sylvia Ln, Allentown, PA 18104-9079 Ph: (610) 481-0895 |
News Archive
A new study has shown that people who frequently attend religious services are significantly more likely to become obese by the time they reach middle age. The finding is surprising especially considering that religious people tend to be in better health than others, said study author Matthew J. Feinstein, a medical student at Northwestern University in Chicago. Feinstein said, "It highlights a particular group that appears to be at a greater risk of becoming obese and remaining obeseā¦It's a group that may benefit from targeted anti-obesity interventions and from obesity prevention programs."
Patients with the skin disease vitiligo may benefit from surgery in which skin cells from unaffected areas of the body are transplanted into damaged areas to restore color, say researchers.
Over the past decade, drug-related poisonings have been on the rise in the United States. In fact, in many states drug-related poisoning deaths have now surpassed motor vehicle crash fatalities to become the leading cause of injury death. While the fatalities from this epidemic have been well reported, they are only the tip of the iceberg.
Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., announced today that the Reproductive Health Drugs Advisory Committee of the U.S. Food and Drug Administration voted that the overall risk/benefit assessment supports approval of mirabegron for the treatment of overactive bladder.
› Verified 1 days ago
Robert Dedio, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1575 Pond Rd, Ste 203, Allentown, PA 18104 Phone: 610-366-1366 | |
Dr. Robert D Strauss, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4734 Lynnfield Ln, South Gate, Allentown, PA 18104 Phone: 610-391-1810 | |
Hilary Koprowski Ii, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1575 Pond Rd, Ste 203, Allentown, PA 18104 Phone: 610-366-1366 Fax: 610-366-7412 | |
Niketu Patel, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1575 Pond Rd, Ste 203, Allentown, PA 18104 Phone: 610-366-1366 Fax: 610-366-7412 | |
Paul Stuart Lemberg, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1575 Pond Rd, Ste 203, Allentown, PA 18104 Phone: 610-366-1366 Fax: 610-366-7412 | |
Dr. Karen Shemanski, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1575 Pond Rd Ste 203, Allentown, PA 18104 Phone: 610-366-1366 |